Description
This presentation discusses the history of insulin, beginning 100 years ago and originally extracted from animals. Today, we have many insulin options. We examine the different types and go into how to select and utilize them for given patient scenarios.
LEARNING OUTCOME: At the conclusion of this activity, the learner will be able to describe the insulin options and how to select for given patient scenarios.
CREDIT HOURS 1.00 NCPD contact hour 0.75 Rx contact hours ACCREDITATION STATEMENT
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN). Anthony J. Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Centers Commission on Accreditation. Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number CEP 5387.
DISCLOSURES Diana Isaacs discloses that she is on theSpeakers Bureau forNovo Nordisk, Dexcom, and Abbott and is aConsultant forLilly, Sanofi, Insulet, and Medtronic. Planning committee members reported no actual or potential conflict of interest in relation to this nursing continuing professional development activity.
LEARNING OUTCOME: At the conclusion of this activity, the learner will be able to describe the insulin options and how to select for given patient scenarios.
CREDIT HOURS 1.00 NCPD contact hour 0.75 Rx contact hours ACCREDITATION STATEMENT
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN). Anthony J. Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Centers Commission on Accreditation. Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number CEP 5387.
DISCLOSURES Diana Isaacs discloses that she is on theSpeakers Bureau forNovo Nordisk, Dexcom, and Abbott and is aConsultant forLilly, Sanofi, Insulet, and Medtronic. Planning committee members reported no actual or potential conflict of interest in relation to this nursing continuing professional development activity.